Product Overview
Semax: Focused Cognitive Support & Neuroprotection
Why Semax is of special interest to patients: Mental fog, stress-related fatigue, or recovery after neurological challenge can limit daily performance. Semax offers gentle, non-sedating support for focus, memory, and brain resilience—especially useful during high-demand periods or aging.
Potential Benefits Shown in Early Limited Evaluations Early studies (animal and small human) suggest:
- Enhanced attention, short-term memory, and learning capacity.
- Faster neurological recovery after stroke or ischemia in supportive settings.
- Improved adaptability under mental or physical stress. These are preliminary observations; broader trials are ongoing.
- Noted: Semax has be stated to be stacked with other peptides. Possibly these stacks may provide for potential enhanced results depending on research indication of interest. These finding are limited and should be researched more fully in human studies for safety and efficacy. Human clinical data remains limited, and it is not FDA-approved for therapeutic use primarily researched or used off-label/investigationally.
Semax is a heptapeptide – 7 amino acids long, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, which is a synthetic analog of a natural fragment of adrenocorticotropic hormone (ACTH 4-10) produced by the body to support brain adaptability and repair.
How it works (Mechanism of Action): Semax modulates dopamine and serotonin systems, increases brain-derived neurotrophic factor (BDNF), and enhances neuro-immune crosstalk—promoting clearer thinking, faster recovery from stress, and neuroprotection.
Backed by science:
- Pre-clinical studies in rodent stroke and stress models showed Semax up-regulates immune and neuroprotective genes while modulating BDNF pathways.
- Clinical data in stroke patients demonstrated improved neurological outcomes and cognitive function when added to standard care.